| Tue, Dec 15, 2009 | | • | Development of ADX10059 Ended for Long-Term Use
Marketwire (Tue, Dec 15)
| | Mon, Dec 14, 2009 | | • | Addex Ends Migraine Prevention Study
Marketwire (Mon, Dec 14)
| | Wed, Dec 2, 2009 | | • | Addex Extends Parkinson's Disease Collaboration with Merck & Co., Inc.
Marketwire (Wed, Dec 2)
| | Tue, Nov 24, 2009 | | • | Addex ADX48621 Positive Primate Parkinson's Data
Marketwire (Tue, Nov 24)
| | Mon, Nov 16, 2009 | | • | Addex ADX10059 Monotherapy is Effective on GERD Symptoms in Phase IIb Clinical Trial
Marketwire (Mon, Nov 16)
| | Tue, Nov 3, 2009 | | • | Addex Presents ADX10059 PD-LID Data at GPCR Drug Discovery Conference
Marketwire (Tue, Nov 3)
| | Mon, Sep 28, 2009 | | • | Addex Completes Enrollment of First Mid-Stage Clinical GERD Trial
Marketwire (Mon, Sep 28)
| | Thu, Sep 17, 2009 | | • | Laurent Massuyeau, Head of Business Development, Resigns
Marketwire (Thu, Sep 17)
| | Mon, Sep 14, 2009 | | • | Addex' ADX10059 has potential for Parkinson's disease levodopa induced dyskinesia (PD-LID)
Marketwire (Mon, Sep 14)
| | Tue, Jul 28, 2009 | | • | Addex Pharmaceuticals Reports First Half 2009 Financial Results
Marketwire (Tue, Jul 28)
| | Thu, Jul 23, 2009 | | • | Addex First Half 2009 Financial Results Tuesday, July 28
Marketwire (Thu, Jul 23)
| | Thu, Jul 16, 2009 | | • | Addex R&D Day Highlights Broadened Therapeutic Potential of Allosteric Modulation Platform to Include Cytokine Receptors as Well as GPCRs
Marketwire (Thu, Jul 16)
| | • | Addex R&D Day Highlights Broadened Therapeutic Potential of Allosteric Modulation Platform to Include Cytokine Receptors as Well as GPCRs
Marketwire (Thu, Jul 16)
| | Fri, Jul 10, 2009 | | • | Addex Achieves Second Milestone in Parkinson's Disease Collaboration With Merck & Co., Inc.
Marketwire (Fri, Jul 10)
| | • | Addex Achieves Second Milestone in Parkinson's Disease Collaboration with Merck & Co., Inc.
Marketwire (Fri, Jul 10)
| | Fri, Jul 3, 2009 | | • | Addex to Host R&D Day on July 16
Marketwire (Fri, Jul 3)
| | • | Addex to Host R&D Day on July 16
Marketwire (Fri, Jul 3)
| | Wed, Jun 24, 2009 | | • | Addex Partner Starts First-Ever Clinical Trial of an mGluR Positive Allosteric Modulator
Marketwire (Wed, Jun 24)
| | • | Addex Partner Starts First-Ever Clinical Trial of an mGluR Positive Allosteric Modulator
Marketwire (Wed, Jun 24)
| | Wed, May 27, 2009 | | • | Glutamate Receptor "mGluR5" Implicated in GERD
Marketwire (Wed, May 27)
|
Add ADXN.SW News to My Yahoo!:
 
| |
|
0.20% Nasdaq 
Headlines
